Adopting a digital-first clinical approach, Healios has redefined the way mental health, autism and ADHD services are delivered to children, young people and families in the UK since it launched in 2013.
Existing investors Albion Capital and InHealth Ventures joined the multi-million-pound funding round, along with new investor Autism Impact Fund (AIF). Healios will use the £14m to scale the company’s presence in the US via its wholly-owned subsidiary, Meliora. Launched in January this year and currently operating in New York and Pennsylvania, Meliora will use the capital to embark on a multi-state expansion.
Investment will also be made into new assessment and intervention programmes, in addition to the expansion of groundbreaking machine learning, data science expertise and clinical research programmes across the two companies.
Healios and Meliora offer a combination of self-management apps alongside online video sessions – including clinical assessments, cognitive behavioural therapy and goal-based interventions – to children and young people with a broad set of complex needs covering conditions such as anxiety, depression, eating disorders, autism and ADHD.
To date, Healios has contracted with 62% of England’s NHS mental health trusts, as well as health boards in Scotland and Wales, to provide high-quality and accessible clinician-led care.
RELATED: Ibex Medical Analytics Secures $10M Funding from Kreos Capital
Rich Andrews, Healios’ Founder and CEO, said:
This new funding from our existing investors, as well as Autism Impact Fund, is a significant milestone in our continued drive to reimagine children’s mental healthcare across the globe. It’s an important recognition of our established clinical reputation of delivering high-quality virtual care and is also a testament to the significant traction we’ve made towards transforming the healthcare system in the UK. The funding will enable us to expand the reach of our platform in the US – potentially supporting tens of thousands of more children, young people and families.
Cat McDonald, Investment Director at Albion capital, comments:
Since we first met Rich in 2018, we have been hugely impressed by his vision and commitment to building a global platform. Healios has already delivered care to thousands of patients and their families in the UK and this funding round is an important milestone in helping Healios scale in the US and achieve its mission of making mental health, autism and ADHD support accessible to every child, everywhere. We can’t wait to continue our partnership with the Healios team, as well as with InHealth Ventures and now AIF.
Follow the latest news on Guided Solutions
